Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Dermatology
Study Phase : Discovery
Sponsor : Leo Pharma
Deal Size : Undisclosed
Deal Type : Collaboration
Sequence Bio Announces Discovery Collaboration Agreement with LEO Pharma
Details : LEO Pharma will leverage insights generated under this collaboration to build robust evidence in support of new potential approaches that significantly impact dermatologic conditions.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
April 07, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Dermatology
Highest Development Status : Discovery
Sponsor : Leo Pharma
Deal Size : Undisclosed
Deal Type : Collaboration